- Staat
- -
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 05.08.2022
- Impfdatum
- 19.07.2022
- Beginn
- 19.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Cardio-respiratory arrest
Cerebellar haemorrhage
Unresponsive to stimuli
Symptomtext
Narrative: 70 year old male with uncontrolled hypertension presented to primary care clinic to re-establish care. BP was elevated upon check in (166/112) - was offered TDaP vaccine. A few minutes after vaccine administration, patient became unresponsive and a code was called. Patient was transferred to ED where he was diagnosed with right cerebellar hemorrhage. Patient transferred to another hospital for higher level of care and neurosurgical services for likely surgery.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardio-respiratory arrest
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 18,0
- Geschlecht
- M
- Eingang
- 15.06.2022
- Impfdatum
- 15.06.2022
- Beginn
- 15.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Syncope
Tremor
Symptomtext
Pt colapsed and shook for about 15 seconds before "waking up"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- N/A
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 07.08.2023
- Impfdatum
- 01.08.2023
- Beginn
- 01.08.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site urticaria
Rash macular
Urticaria
Symptomtext
within minutes of receiving the TdaP vaccine, pt. developed urticaria at the site of the injection that spread around the deltoid and down to the mid arm. The welts were not itchy and patient did not have any dyspnea, wheezing or anaphylactic reaction and BP/VS remained stable. Patient had a dose of Benadryl 25 my orally and observed for 1 hour in the office. The Urticaria (welts) started going away after 30 minutes and by 1 hours only a macular rash remained.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site urticaria
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Hx of gastroschisis, S/P surgical repair as an infant with small bowel resection
- Andere Medikamente
- none
- Allergien
- Peanut, sesame
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 19.03.2023
- Impfdatum
- 15.03.2023
- Beginn
- 15.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Erythema
Injection site erythema
Injection site swelling
Nervousness
Pain
Peripheral swelling
Pyrexia
Symptomtext
Fever, chills, body pain, arm red at injection site and swollen. Not warm to the touch. Fever broke after 2 days. Patient feels like she is shaking from the inside of her body. Arm is still red and swollen on day 5.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- FIBROMYALGIA, HIGH BLOOD PRESSURE. HISTORY OF COVID AND SHINGLES
- Andere Medikamente
- ASPIRIN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 29,0
- Geschlecht
- M
- Eingang
- 08.03.2023
- Impfdatum
- 05.03.2023
- Beginn
- 06.03.2023
- Tage bis Beginn
- 1,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Back pain
Flank pain
Lymphadenopathy
Neck pain
Pain in extremity
Pyrexia
Symptomtext
The pt is experiencing fever, a sore and achy arm from the elbow upward, pain in the side and back (also experienced with COVID vaccine), swollen lymph node and neck pain.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Back pain
- Hospital-Tage
- -
- Labordaten
- Unknown at this time
- Aktuelle Erkrankungen
- None Known
- Vorgeschichte
- High blood pressure
- Andere Medikamente
- Carvedilol 12.5 mg -1 bid
- Allergien
- None
- Vorherige Impfungen
- COVID ..fever, pain in side and back
- Staat
- TX
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 07.03.2023
- Impfdatum
- 21.02.2023
- Beginn
- 21.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood creatine phosphokinase normal
Pain in extremity
Red blood cell sedimentation rate normal
Sleep disorder
Symptomtext
Patient was given her 10 year booster update for Tdap on day of her physical exam. Later that night she began to have severe bilateral leg pain that woke her up from sleep. She continued to have this pain mainly at night when she lied down for the next few days and her itraconazole and statin medications were stopped to see if they were contributing. As of 3/7/23 she continues to have bilateral severe leg pain at night despite stopping these medications and with no other symptoms. Her creatinine kinase and ESR are both normal. She was just started on gabapentin last night with some relief. Lumbar spine x-rays are pending. Due the acute onset of the pain on the night of her exam with no other precipitating events or injuries, and the severity of symptoms I thought it should be reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- Creatinine kinase of 25 U/L and ESR of 9 mm/h, which are both well within normal range. Physical exam showed normal strength throughout, no tenderness to palpation, negative straight leg tests bilaterally, pulses 2+ bilaterally, no edema to legs or joints and reflexes were 2+ bilaterally. Normal sensation as well. Lumbar x-rays (5 views) are pending.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Seasonal allergies, osteopenia, osteoarthritis, atherosclerosis, onychomycosis, hyperlipidemia
- Andere Medikamente
- zyrtec, vitamin D, Multivitamin, flonase, glucosamine chondroitin, Aspirin, Pravastatin, Itraconazole
- Allergien
- Augmentin
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 01.03.2023
- Impfdatum
- 10.01.2023
- Beginn
- 11.01.2023
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Erythema
Pain in extremity
Peripheral swelling
Symptomtext
On 1/11/23 (1 day after vaccines), patient developed large area of redness and swelling in left arm along with pain . Mom advised to treat with compresses and give tylenol and advil for pain. Mom notes on 1/13/23 symptoms improving. Mom states symptoms took 1 week to resolve in total
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 12.01.2023
- Impfdatum
- 10.01.2023
- Beginn
- 11.01.2023
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site rash
Injection site swelling
Symptomtext
Redness, Swelling, and Bumps to the injection site. Physician recommended Benadryl to help with any itching and the rash as well as Ibuprofen to help with any pain and the swelling. Recommend the Ibuprofen every 6 hours for at least 24-48 hours and the benadryl every 6 hours as needed for itching.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 06.12.2022
- Impfdatum
- 07.09.2022
- Beginn
- 12.09.2022
- Tage bis Beginn
- 5,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site haematoma
Injection site pain
Pain
Pruritus
Quality of life decreased
Symptomtext
Medical resident injected approximately 9CMs below acromion process. Did not check for landmark. Stated when offered by NP in clinic to give the injection said she had given before and before I could say anything she gave the injection. No pain but approximately three days later noticed a hematoma at site and itching. Over time have developed pain with various movements of arm and with extension developed moderate to severe cramping at site. Negative impact on quality of life at this point.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site haematoma
- Hospital-Tage
- -
- Labordaten
- No
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Hypothyroidism, Hypertension
- Andere Medikamente
- Amlodipine, Losartan, Levothyroxine, Atorvastatin
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 27.10.2022
- Impfdatum
- 24.10.2022
- Beginn
- 25.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cellulitis
Erythema
Pain
Skin warm
Swelling
Symptomtext
REDNESS, SWELLING, PAIN, HOT TO THE TOUCH DX: CELLULITIS BEING TREATED WITH KEFLEX
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- SHORT STATURE
- Andere Medikamente
- NONE
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 05.10.2022
- Impfdatum
- 27.09.2022
- Beginn
- 27.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 6
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Pain in extremity
Product administered to patient of inappropriate age
Symptomtext
On 9/29/22 Health Dept. called to clarify which vaccine was given. it was at that point I realized the Pfizer bivalent vaccine was given and the patient is not 12 years old yet. MD was notified. Department manager, RN was notified. Father was notified on 9/29/22. Dad stated she had sore arms the day after her 4 vaccines, but has not had any adverse effects other than that.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None known
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 13.08.2022
- Impfdatum
- 06.08.2022
- Beginn
- 08.08.2022
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Contusion
Erythema
Pain
Swelling
Symptomtext
redness, bruising, swelling , pain and tenderness occurred on monday and began to improve on thursday. Using cold packs at injection site.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- type 2 diabetes, hypertension
- Andere Medikamente
- unknown
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 12.08.2022
- Impfdatum
- 10.08.2022
- Beginn
- 10.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 7+
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Urticaria
Symptomtext
Patient developed hives approximately 4 hours after receiving Tdap. She has been taking Benadryl OTC since hives began.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 10,0
- Geschlecht
- F
- Eingang
- 23.06.2022
- Impfdatum
- 22.06.2022
- Beginn
- 22.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Hyperhidrosis
Nausea
Pallor
Vomiting
Symptomtext
Nausea, dizzy, vomited. She was pale and diaphoretic. No loss of consciousness. We had her lay down and applied a cool towel to her forehead. After 5 minutes, she seemed back to her baseline.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- BP- 90/58 Pulse Ox- 98%
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none known
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 14,0
- Geschlecht
- F
- Eingang
- 17.05.2022
- Impfdatum
- 06.05.2022
- Beginn
- 17.05.2022
- Tage bis Beginn
- 11,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal mass
Fatigue
Pyrexia
Rash
Rash pruritic
Symptomtext
pt developed a lump / itchy rash on her abdomen day after administration. fatigue, low grade fever. treatment has been rest and OTC hydrocortisone cream for the itching.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- depression joint pain
- Vorgeschichte
- depression joint pain
- Andere Medikamente
- none
- Allergien
- amoxicillin
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 40,0
- Geschlecht
- F
- Eingang
- 27.04.2022
- Impfdatum
- 25.04.2022
- Beginn
- 26.04.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenopia
Feeling of body temperature change
Hyperhidrosis
Lymphadenopathy
Pain in extremity
Symptomtext
Sweats, hot and cold, arm pain, swollen axillary lymph nodes, heavy eyes started at 24 hours after injection.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- migraines, sleep apnea, vitamin D deficiency, HSV
- Andere Medikamente
- Tylenol, Omeprazole, tizanidine.
- Allergien
- flu vaccine, contrast dye
- Vorherige Impfungen
- flu vaccine
- Staat
- OH
- Alter
- 42,0
- Geschlecht
- F
- Eingang
- 19.02.2022
- Impfdatum
- 16.02.2022
- Beginn
- 17.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Pain in extremity
Symptomtext
Patient has a red, sore arm since the day after receiving the vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 13,0
- Geschlecht
- M
- Eingang
- 21.12.2022
- Impfdatum
- 16.08.2022
- Beginn
- 12.12.2022
- Tage bis Beginn
- 118,0
- Dosis
- 2
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
No adverse event
Symptomtext
ADACEL that were administered in August were administered in error again yesterday with no reported adverse event; Initial information received on 13-Dec-2022 regarding an unsolicited valid non-serious case received from a consumer/non-health care professional. This case is linked to case 2022SA507244(CLUSTER). This case involves a 13 years old male patient who experienced adacel that were administered in august were administered in error again yesterday with no reported adverse event after receiving vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HEPATITIS A VACCINE,HEPATITIS B VACCINE (and VARICELLA ZOSTER VACCINE for Prophylactic vaccination. On 16-Aug-2022 he also received a (series-1)dose of the suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE(Dose-0.5mL)(Frequency-Total)( Strength = STANDARD) (Batch/lot number-U7283AA) via intramuscular route in the right deltoid for Immunization. On 12-Dec-2022, the patient received a (series-2)dose of Same suspect(Dose-0.5mL)(Frequency-Total)(Strength = STANDARD) via intramuscular route in right deltoid for Immunization (Batch Number/Lot Number, Expiry date: Unknown) On 12-DEC-2022 the patient developed a non-serious event Adacel that were administered in august were administered in error again yesterday with no reported adverse event (inappropriate schedule of product administration)(Latency- 3 months 27 days) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. Action Taken : Not applicable. At time of reporting, the outcome was Unknown for the event This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- HEPATITIS A VACCINE; HEPATITIS B VACCINE; VARICELLA ZOSTER VACCINE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 15.08.2022
- Impfdatum
- 13.08.2022
- Beginn
- 15.08.2022
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
pt received boostrix on 4/12/22 and then received adacel on 8/13/22, missed previous dosage of boostrix- doctors office caught the duplication, patient is not experiencing any side effects at this time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- arthritis, bacterial infection, dermatologic disoder, obesity, depression, diabetes, high cholesterol
- Vorgeschichte
- arthritis, dermatologic disorder, obesity, depression, diabetes, high cholesterol
- Andere Medikamente
- humira, mupirocin, cipro, omeprazole, lovastatin, famotidine, ozempic, tresiba, insulin lispro, breo ellipta,
- Allergien
- no allergies list
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 49,0
- Geschlecht
- M
- Eingang
- 25.07.2022
- Impfdatum
- 16.06.2022
- Beginn
- 04.07.2022
- Tage bis Beginn
- 18,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Treponema test false positive
Symptomtext
false positive syphilis test; Initial information received on 21-Jul-2022 regarding an unsolicited valid non-serious case received from a consumer/non-hcp. This case involves a 49 years old male patient who had false positive syphilis test after receiving vaccine diphtheria-2/tetanus/5 AC pertussis vaccine. The patient's past vaccination(s) included FLUARIX. The patient's past medical history, medical treatment(s) and family history were not provided. On 16-Jun-2022, the patient received 0.5ml dose of suspect diphtheria-2/tetanus/5 AC pertussis vaccine, suspension for injection (lot U7283AA; strength and expiry date not reported) via intramuscular route in the left arm for Immunization. Patient states that he received a Sanofi Tdap vaccination on 16-Jun-2022 from his doctor and was not certain of the brand name of the vaccine. On 04-Jul-2022 the patient states that when he attempted to donate blood and he received false positive syphilis test (treponema test false positive) (latency:18 days). Patient states that this also happened to him approximately 2 years ago after he received a FLUARIX vaccine from GSK and received a false positive syphilis test when attempting to donate blood. Patient asked if there was any way to compare these two vaccines and was any information available regarding the Sanofi Tdap vaccine that he received causing false positive syphilis tests; Relevant laboratory test results included: Treponema test - On 04-Jul-2022: [false positive syphilis test] Action taken : not applicable. It was not reported if the patient received a corrective treatment for the event (false positive syphilis test). At time of reporting, the outcome was Unknown for the event false positive syphilis test.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Treponema test false positive
- Hospital-Tage
- -
- Labordaten
- Test Date: 20220704; Test Name: syphilis test; Result Unstructured Data: false positive syphilis test
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 17.06.2022
- Impfdatum
- 07.06.2022
- Beginn
- 07.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
poor quality vaccine administered; states that their refrigerator with vaccines previously experienced a temperature excursion that reached 37.2C and the vaccines were deemed not suitable for use with no reported adverse event; Initial information received on 07-Jun-2022 regarding an unsolicited valid non-serious case received from a consumer/non-hcp. This case involves a 11 years old female patient who experienced states that their refrigerator with vaccines previously experienced a temperature excursion that reached 37.2c and the vaccines were deemed not suitable for use with no reported adverse event and poor quality vaccine administered while receiving vaccine diphtheria-2/tetanus/5 AC pertussis vaccine [adacel]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included meningococcal vaccine A/C/Y/W CONJ (dip tox) (menactra) for Immunisation. On 07-Jun-2022, the patient received a 0.5 ml dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (lot U7283AA; expiry date: 02-Feb-2022) via intramuscular route in the right deltoid for prophylactic vaccination. On 07-Jun-2022 the patient reported refrigerator with vaccines previously experienced a temperature excursion that reached 37.2c and the vaccines were deemed not suitable for use with no reported adverse event (product storage error) following the administration of diphtheria-2/tetanus/5 AC pertussis vaccine. On an unknown date the patient developed a non-serious poor quality vaccine administered (poor quality product administered) (unknown latency) following the administration of diphtheria-2/tetanus/5 AC pertussis vaccine. Action taken: not applicable. It was not reported if the patient received a corrective treatment for the events. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: 01135750:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- MENACTRA
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- -
- Geschlecht
- U
- Eingang
- 05.03.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
unopened ADACEL and TUBERSOL as well as punctured TUBERSOL, exposed to 64 F for 24 hours, with no reported adverse event; Initial information received on 23-Feb-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a patient with unknown demographics who had unopened adacel and tubersol as well as punctured tubersol, exposed to 64 f for 24 hours, with no reported adverse event while receiving vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] and while treated with TUBERCULIN TEST [TUBERSOL]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient started taking TUBERSOL (TUBERCULIN TEST) Solution for injection dosage unknown (lot - C5841AB, 17-Jan-2023)for unknown indication. On an unknown date, the patient received a dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE with unknown dosing lot U7283AA via unknown route in unknown administration site for immunization. On an unknown date the patient had unopened adacel and tubersol as well as punctured tubersol, exposed to 64 f for 24 hours, with no reported adverse event (product temperature excursion issue) (unknown latency) following the first dose intake and (unknown latency) following the last dose intake of TUBERCULIN TEST. On an unknown date the patient developed a non-serious unopened adacel and tubersol as well as punctured tubersol, exposed to 64 f for 24 hours, with no reported adverse event (product temperature excursion issue) (unknown latency) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event (unopened ADACEL and TUBERSOL as well as punctured TUBERSOL, exposed to 64 F for 24 hours, with no reported adverse event). At time of reporting, the outcome was Unknown for the event unopened adacel and tubersol as well as punctured tubersol, exposed to 64 f for 24 hours, with no reported adverse event.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- TUBERSOL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 28,0
- Geschlecht
- F
- Eingang
- 17.01.2022
- Impfdatum
- 07.01.2022
- Beginn
- 07.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exposure during pregnancy
No adverse event
Symptomtext
This case involves 28 years old female patient who was exposed to vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] in context of patient is pregnant with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported patient is pregnant with no reported adverse event occurred at 33 weeks of pregnancy. The date of last menstrual period was reported as 18-May-2021. The estimated due date is 22-Feb-2022. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had unknown previous pregnancy/ies. On 07-Jan-2022, the patient received 0.5 ml dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE, frequency once, lot U7283AA, expiry date: 02-Feb-2024 via intramuscular route in the left deltoid (formulation, strength: not reported) as prophylactic vaccination (TB skin test--immunization). On 07-JAN-2022 the patient developed a non-serious event "patient is pregnant with no reported adverse event "(exposure during pregnancy) (latency same day) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. It was reported "Dose = 0.25 mL to 2 mL for vaccines or 0.1 mL for TB skin test--0.5ml o Strength = standard except for Fluzone HD--standard o Indications = Immunization or TB skin test--immunization" Action taken with DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE (ADACEL) was not applicable. It was not reported if the patient received a corrective treatment for the event (patient is pregnant with no reported adverse event). At time of reporting, the outcome was Unknown for the event patient is pregnant with no reported adverse event. Additionally, at time of reporting, the pregnancy is still ongoing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Exposure during pregnancy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -